Literature DB >> 27142513

Correlation Between Meis1 and Msi1 in Esophageal Squamous Cell Carcinoma.

Meysam Moghbeli1, Abolfazl Rad2, Moein Farshchian3, Negin Taghehchian1, Mehran Gholamin1, Mohammad Reza Abbaszadegan4,5.   

Abstract

PURPOSE: Homeobox (HOX) transcription factors are critical regulators of cell fate, stem cell functions, and gastrointestinal development. They require three-amino acid loop extension (TALE) homeodomain proteins such as Meis1 to enhance their transcriptional efficiencies. There are complicated associations between different signaling pathways such as the Wnt and NOTCH and tumor progression. It has been investigated that GSK-3 as an important component of the Wnt pathway facilitates the expression of HOX target genes. Therefore, in the present study, we assessed the probable correlation between Wnt, NOTCH, and HOX genes in esophageal squamous cell carcinoma (ESCC) progression and metastasis through the correlational study between the Msi1 as an important activator for both of the NOTCH and Wnt pathways and Meis1.
METHODS: Levels of Meis1 and Msi1 messenger RNA (mRNA) expression in 51 ESCC patients were compared to the normal tissues using real-time polymerase chain reaction.
RESULTS: Only 3 out of 51 (5.9 %) cases had Meis1/Msi1 overexpression and also 3/51 (5.9 %) cases had Meis1/Msi1 underexpression. There was a significant correlation between the Msi1 and Mesi1 mRNA expression (p = 0.037). All of the Msi1/Meis1 underexpressed tumors were poorly differentiated (p = 0.003). Meis1 under/Msi1 overexpressed cases also were in T3 tumor depth of invasion (p = 0.019). And there was a significant correlation between the Msi1/Meis1 underexpression and gender (p = 0.045).
CONCLUSIONS: Our results show that Meis1 may have a positive feedback with Msi1 during the ESCC progression.

Entities:  

Keywords:  Expression; HOX; NOTCH; Signaling pathway; WNT

Mesh:

Substances:

Year:  2016        PMID: 27142513     DOI: 10.1007/s12029-016-9824-6

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  28 in total

1.  The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA.

Authors:  T Imai; A Tokunaga; T Yoshida; M Hashimoto; K Mikoshiba; G Weinmaster; M Nakafuku; H Okano
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

2.  PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1.

Authors:  K Monica; N Galili; J Nourse; D Saltman; M L Cleary
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

3.  GSK-3 promotes conditional association of CREB and its coactivators with MEIS1 to facilitate HOX-mediated transcription and oncogenesis.

Authors:  Zhong Wang; Masayuki Iwasaki; Francesca Ficara; Chenwei Lin; Christina Matheny; Stephen H K Wong; Kevin S Smith; Michael L Cleary
Journal:  Cancer Cell       Date:  2010-06-15       Impact factor: 31.743

4.  Follicle stimulating hormone-induced growth promotion and gene expression profiles on ovarian surface epithelial cells.

Authors:  Qing Ji; Paul I Liu; Peter K Chen; Chisa Aoyama
Journal:  Int J Cancer       Date:  2004-12-10       Impact factor: 7.396

5.  HOXA9 modulates its oncogenic partner Meis1 to influence normal hematopoiesis.

Authors:  Yu-Long Hu; Steve Fong; Christina Ferrell; Corey Largman; Wei-Fang Shen
Journal:  Mol Cell Biol       Date:  2009-07-20       Impact factor: 4.272

Review 6.  HOX and non-HOX homeobox genes in leukemic hematopoiesis.

Authors:  Bronwyn M Owens; Robert G Hawley
Journal:  Stem Cells       Date:  2002       Impact factor: 6.277

7.  HOXA5-induced apoptosis in breast cancer cells is mediated by caspases 2 and 8.

Authors:  Hexin Chen; Seung Chung; Saraswati Sukumar
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

8.  Characterization of PREP2, a paralog of PREP1, which defines a novel sub-family of the MEINOX TALE homeodomain transcription factors.

Authors:  C Fognani; C Kilstrup-Nielsen; J Berthelsen; E Ferretti; V Zappavigna; F Blasi
Journal:  Nucleic Acids Res       Date:  2002-05-01       Impact factor: 16.971

9.  Transcriptional activation by MEIS1A in response to protein kinase A signaling requires the transducers of regulated CREB family of CREB co-activators.

Authors:  Siew-Lee Goh; Yvonne Looi; Hui Shen; Jun Fang; Caroline Bodner; Martin Houle; Andy Cheuk-Him Ng; Robert A Screaton; Mark Featherstone
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

10.  Hypomorphic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype.

Authors:  Elisabetta Ferretti; J Carlos Villaescusa; Patrizia Di Rosa; Luis C Fernandez-Diaz; Elena Longobardi; Roberta Mazzieri; Annarita Miccio; Nicola Micali; Licia Selleri; Giuliana Ferrari; Francesco Blasi
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

View more
  18 in total

1.  MiR-330-3p inhibits gastric cancer progression through targeting MSI1.

Authors:  Aoran Guan; Hui Wang; Xun Li; Hui Xie; Ruotian Wang; Yankun Zhu; Ruhong Li
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

2.  Role of MAML1 and MEIS1 in Esophageal Squamous Cell Carcinoma Depth of Invasion.

Authors:  Mohammad Reza Abbaszadegan; Meysam Moghbeli
Journal:  Pathol Oncol Res       Date:  2017-05-01       Impact factor: 3.201

Review 3.  MicroRNA-96: A therapeutic and diagnostic tumor marker.

Authors:  Hamid Reza Rahimi; Majid Mojarrad; Meysam Moghbeli
Journal:  Iran J Basic Med Sci       Date:  2022-01       Impact factor: 2.532

4.  Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma.

Authors:  Guohui Qin; Jingyao Lian; Dongli Yue; Xinfeng Chen; Shufeng Nan; Yu Qi; Bing Li; Guanghui Cui; Xiangnan Li; Song Zhao; Yi Zhang
Journal:  Oncol Rep       Date:  2017-07-12       Impact factor: 3.906

5.  Contribution of KCTD12 to esophageal squamous cell carcinoma.

Authors:  Mohammad Reza Abbaszadegan; Negin Taghehchian; Liping Li; Azadeh Aarabi; Meysam Moghbeli
Journal:  BMC Cancer       Date:  2018-08-29       Impact factor: 4.430

6.  Role of MAML1 in targeted therapy against the esophageal cancer stem cells.

Authors:  Meysam Moghbeli; Hooman Mosannen Mozaffari; Bahram Memar; Mohammad Mahdi Forghanifard; Mehran Gholamin; Mohammad Reza Abbaszadegan
Journal:  J Transl Med       Date:  2019-04-16       Impact factor: 5.531

Review 7.  Genetic and molecular bases of esophageal Cancer among Iranians: an update.

Authors:  Mohammad Reza Abbaszadegan; Vahideh Keyvani; Meysam Moghbeli
Journal:  Diagn Pathol       Date:  2019-08-31       Impact factor: 2.644

8.  MEIS-1 level in unresectable hepatocellular carcinoma can predict the post-treatment outcomes of radiofrequency ablation.

Authors:  Hui Xie; Haipeng Yu; Shengtao Tian; Xueling Yang; Ximing Wang; Huaming Wang; Zhi Guo
Journal:  Oncotarget       Date:  2018-01-11

9.  WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma.

Authors:  Mohammad Reza Abbaszadegan; Anali Riahi; Mohammad Mahdi Forghanifard; Meysam Moghbeli
Journal:  Cell Mol Biol Lett       Date:  2018-09-03       Impact factor: 5.787

Review 10.  Genetics of blood malignancies among Iranian population: an overview.

Authors:  Majid Ghayour-Mobarhan; Amir Sadra Zangouei; Seyed Mohammad Hosseinirad; Majid Mojarrad; Meysam Moghbeli
Journal:  Diagn Pathol       Date:  2020-05-06       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.